Skip to content

Celldex Therapeutics, Inc.: filings

Every Celldex Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 62 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 202636990001104659-26-091984
10-Q2026-05-07fiscal Q1 202635740001104659-26-057113
10-K2026-02-25fiscal FY 2025431100001104659-26-019652
10-Q2025-11-10fiscal Q3 2025361020001104659-25-109137
10-Q2025-08-07fiscal Q2 202536990001410578-25-001610
10-Q2025-05-08fiscal Q1 202535730001410578-25-001111
10-K2025-02-27fiscal FY 2024401010001410578-25-000216
10-Q2024-11-06fiscal Q3 2024351010001410578-24-001766
10-Q2024-08-08fiscal Q2 202435970001410578-24-001219
10-Q2024-05-06fiscal Q1 202435730001410578-24-000593
10-K2024-02-26fiscal FY 2023411020001410578-24-000076
10-Q2023-11-02fiscal Q3 2023341000001410578-23-002169
10-Q2023-08-08fiscal Q2 202334960001410578-23-001588
10-Q2023-05-04fiscal Q1 202334720001104659-23-055992
10-K2023-02-28fiscal FY 2022411030001104659-23-026701
10-Q2022-11-09fiscal Q3 2022371070001104659-22-116466
10-Q2022-08-08fiscal Q2 2022351000001104659-22-087222
10-Q2022-05-05fiscal Q1 202235740001104659-22-056442
10-K2022-02-28fiscal FY 2021411030001104659-22-028070
10-Q2021-11-09fiscal Q3 202132930001104659-21-136268
10-Q2021-08-05fiscal Q2 202132860001104659-21-100745
10-Q2021-05-06fiscal Q1 202131650001104659-21-062387
10-K2021-03-29fiscal FY 2020371080001104659-21-043161
10-Q2020-11-05fiscal Q3 202032900001104659-20-121786
10-Q2020-08-06fiscal Q2 202032860001104659-20-091459
10-Q2020-05-06fiscal Q1 202030650001104659-20-057436
10-K2020-03-26fiscal FY 2019371050001047469-20-001809
10-Q2019-11-12fiscal Q3 201935940001104659-19-062181
10-Q2019-08-07fiscal Q2 201934880001104659-19-044531
10-Q2019-05-07fiscal Q1 201935700001104659-19-027513
10-K2019-03-07fiscal FY 2018371060001047469-19-000992
10-Q2018-11-07fiscal Q3 201833840001104659-18-066648
10-Q2018-08-08fiscal Q2 201833820001104659-18-050496
10-Q2018-05-10fiscal Q1 201832640001104659-18-031972
10-K2018-03-07fiscal FY 2017351040001047469-18-001363
10-Q2017-11-07fiscal Q3 201734850001104659-17-066472
10-Q2017-08-08fiscal Q2 201731780001104659-17-050250
10-Q2017-05-09fiscal Q1 201728570001104659-17-031139
10-K2017-03-14fiscal FY 201630900001047469-17-001564
10-Q2016-11-07fiscal Q3 201628720001104659-16-155185
10-Q2016-08-08fiscal Q2 201629740001104659-16-137913
10-Q2016-05-05fiscal Q1 201629590001104659-16-118017
10-K/A2016-02-25fiscal FY 201532930001047469-16-010396
10-K2016-02-23fiscal FY 201532930001047469-16-010308
10-Q2015-11-05fiscal Q3 201529740001104659-15-076295
10-Q2015-08-10fiscal Q2 201528720001104659-15-058233
10-Q2015-04-29fiscal Q1 201528590001104659-15-031298
10-K2015-02-24fiscal FY 201431930001047469-15-001081
10-Q2014-11-05fiscal Q3 201429740001104659-14-076822
10-Q2014-08-07fiscal Q2 201429740001104659-14-057922
10-Q2014-05-01fiscal Q1 201429600001104659-14-033059
10-K2014-03-03fiscal FY 201332950001047469-14-001653
10-Q2013-11-08fiscal Q3 201329770001104659-13-082619
10-Q2013-08-06fiscal Q2 201329770001104659-13-060226
10-Q2013-05-03fiscal Q1 201329600001104659-13-036833
10-K2013-03-08fiscal FY 201232950001047469-13-002403
10-Q2012-11-02fiscal Q3 201230800001104659-12-073441
10-Q2012-08-09fiscal Q2 201230800001104659-12-056527
10-Q2012-05-04fiscal Q1 201232650001104659-12-032960
10-K2012-03-08fiscal FY 201134870001047469-12-002276
10-Q2011-11-03fiscal Q3 201131840001104659-11-060466
10-Q2011-08-04fiscal Q2 201134900001104659-11-043630

Inspect the source

Entity
Celldex Therapeutics, Inc. / CIK 0000744218
Captured
2026-09-19T15:01:25.275Z
SEC response SHA-256
a253f724b1319f3eeec0fb678b43576159c8fa993fc97e4268adfafa9963e2f2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000744218.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))